Annual Report 2017
Division of Cancer Statistics Integration
Kota Katanoda, Megumi Hori, Eiko Saito, Hiroko Takamatsu
The Division of Cancer Statistics Integration, newly opened in FY2017, develops and analyzes comprehensive cancer statistics information including cancer registry data in order to contribute to the development and evaluation of evidence-based cancer control.
Our team and what we do
1. Analysis of cancer statistics information
Cancer statistics, including cancer registry data, need to be scientifically analyzed to serve as correct, useful and interpretable source of information. The Division of Cancer Statistics Integration is responsible for analyzing and developing cancer statistics information including cancer registry data to address a variety of needs of public health, clinical and basic sciences. The cancer statistics we provide are widely used by researchers, policy makers, mass media, health-care providers, patients and citizens.
2. Integration of cancer statistics to develop and evaluate evidence-based cancer control policies
Cancer control policies need to be developed and evaluated based on scientific evidence. For this purpose, the Division of Cancer Statistics Integration combines cancer statistics information with a variety of information regarding prevention, early detection, diagnosis, treatment, palliative care, and health economics, and mathematically analyzes the effects of cancer control policies.
1. Cancer statistics web site in the "Cancer Information Service"
Cancer statistics data and graphical information such as cancer incidence, mortality, and survival are provided on the web site in the "Cancer Information Service", managed by the Center for Cancer Control and Information Services at the National Cancer Cernter (NCC). Our analysis using cancer statistics information is published as a scientific publication in the Japanese Journal of Clinical Oncology (JJCO) and other academic journals. For general public, the booklet "Cancer Statistics" is also annually published. This fiscal year, we provided cancer mortality data in 2016, cancer incidence data in 2013, long-term prediction data up to 2039, childhood and AYA (adolescent and young adult) cancer incidence data, and published the booklet "Cancer statistics in Japan'17".
2. Research on cancer statistics and cancer control
Cancer statistics information combined with information on cancer prevention, early detection, diagnosis, treatment, palliative care, and health economics is analyzed in order to develop and evaluate cancer control policies. This fiscal year, in addition to analyzing the cancer incidence rates among children and AYA, the cumulative risk of stomach cancer was estimated according to major risk factors, and the secular trend of neuroblastoma incidence and mortality was analyzed after the halt of the national mass screening program.
Our research activities also cover a variety of analysis on cancer prevention, early detection, treatment, etc. In this fiscal year, we conducted research on the relationship between birth weight and adult-onset diabetes, and research on the reduction of cancer risk after smoking cessation.
Joint graduate school has been started in the field of Cancer Statistics and Informatics in collaboration with Osaka University Graduate School of Medicine.
We have developed a network with the Cancer Intervention and Surveillance Modeling Network (CISNET) group of the National Cancer Institute (NCI) in the United States and sent a member of our staff for a short visit to exchange information and plan future collaboration.
On the basis of the development and analysis of cancer statistics information, we aim to realize effective and efficient cancer control measures through the cancer control continuum from prevention to treatment and palliative care.
List of papers published in January 2017 - March 2018
1. Chen Y, Wu F, Saito E, Lin Y, Song M, Luu HN, Gupta PC, Sawada N, Tamakoshi A, Shu XO, Koh WP, Xiang YB, Tomata Y, Sugiyama K, Park SK, Matsuo K, Nagata C, Sugawara Y, Qiao YL, You SL, Wang R, Shin MH, Pan WH, Pednekar MS, Tsugane S, Cai H, Yuan JM, Gao YT, Tsuji I, Kanemura S, Ito H, Wada K, Ahn YO, Yoo KY, Ahsan H, Chia KS, Boffetta P, Zheng W, Inoue M, Kang D, Potter JD. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia, 60:1022-1032, 2017
2. Katanoda K, Noda M, Goto A, Mizunuma H, Lee JS, Hayashi K. Impact of birth weight on adult-onset diabetes mellitus in relation to current body mass index: The Japan Nurses' Health Study. J Epidemiol, 27:428-434, 2017
3. Saito E, Inoue M, Tsugane S, Ito H, Matsuo K, Wakai K, Wada K, Nagata C, Tamakoshi A, Sugawara Y, Tsuji I, Mizoue T, Tanaka K, Sasazuki S. Smoking cessation and subsequent risk of cancer: A pooled analysis of eight population-based cohort studies in Japan. Cancer Epidemiol, 51:98-108, 2017
4. Shinagawa T, Kitamura T, Katanoda K, Matsuda T, Ito Y, Sobue T. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study. Int J Cancer, 140:618-625, 2017
5. Narita S, Inoue M, Saito E, Abe SK, Sawada N, Ishihara J, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Shibuya K, Tsugane S. Dietary fiber intake and risk of breast cancer defined by estrogen and progesterone receptor status: the Japan Public Health Center-based Prospective Study. Cancer Causes Control, 28:569-578, 2017
6. Teng Y, Saito E, Abe SK, Sawada N, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Inoue M, Tsugane S. Female reproductive factors, exogenous hormone use, and pancreatic cancer risk: the Japan Public Health Center-based prospective study. Eur J Cancer Prev, 26:378-384, 2017
7. Nomura S, Sakamoto H, Glenn S, Tsugawa Y, Abe SK, Rahman MM, Brown JC, Ezoe S, Fitzmaurice C, Inokuchi T, Kassebaum NJ, Kawakami N, Kita Y, Kondo N, Lim SS, Maruyama S, Miyata H, Mooney MD, Naghavi M, Onoda T, Ota E, Otake Y, Roth GA, Saito E, Tabuchi T, Takasaki Y, Tanimura T, Uechi M, Vos T, Wang H, Inoue M, Murray CJL, Shibuya K. Population health and regional variations of disease burden in Japan, 1990-2015: a systematic subnational analysis for the Global Burden of Disease Study 2015. Lancet, 390:1521-1538, 2017
8. Hori M, Katanoda K. Incidence rate for melanoma of skin cancer in Japanese in Japan and in the United States from the Cancer Incidence in Five Continents. Jpn J Clin Oncol, 47:373-374, 2017
9. Sado J, Kitamura T, Kitamura Y, Sobue T, Nishino Y, Tanaka H, Nakayama T, Tsuji I, Ito H, Suzuki T, Katanoda K, Tominaga S. Association between coffee consumption and all-sites cancer incidence and mortality. Cancer Sci, 108:2079-2087, 2017
10. Katanoda K, Hori M. The estimates of 5-year lung cancer prevalence in adult population in 2012. Jpn J Clin Oncol, 47:896-897, 2017
11. Sado J, Kitamura T, Kitamura Y, Zha L, Liu R, Sobue T, Nishino Y, Tanaka H, Nakayama T, Tsuji I, Ito H, Suzuki T, Katanoda K, Tominaga S. Rationale, design, and profile of the Three-Prefecture Cohort in Japan: A 15-year follow-up. J Epidemiol, 27:193-199, 2017
12. Song H, Saito E, Sawada N, Abe SK, Hidaka A, Shimazu T, Yamaji T, Goto A, Iwasaki M, Sasazuki S, Ye W, Inoue M, Tsugane S. Body mass index change during adulthood and risk of oesophageal squamous-cell carcinoma in a Japanese population: the Japan Public Health (JPHC)-based prospective study. Br J Cancer, 117:1715-1722, 2017
13. Katanoda K, Shibata A, Matsuda T, Hori M, Nakata K, Narita Y, Ogawa C, Munakata W, Kawai A, Nishimoto H. Childhood, adolescent and young adult cancer incidence in Japan in 2009-2011. Jpn J Clin Oncol, 47:762-771, 2017
14. Taniyama Y, Katanoda K, Charvat H, Hori M, Ohno Y, Sasazuki S, Tsugane S. Estimation of lifetime cumulative incidence and mortality risk of gastric cancer. Jpn J Clin Oncol, 47:1097-1102, 2017
15. Hori M, Katanoda K. The estimates of 5-year breast cancer prevalence in adult population in 2012. Jpn J Clin Oncol, 47:993-994, 2017
16. Song H, Saito E, Sawada N, Abe SK, Hidaka A, Shimazu T, Yamaji T, Goto A, Iwasaki M, Sasazuki S, Ye W, Inoue M, Tsugane S. Perceived stress level and risk of cancer incidence in a Japanese population: the Japan Public Health Center (JPHC)-based Prospective Study. Sci Rep, 7:12964, 2017
17. Katanoda K, Hori M. Incidence rate for gallbladder cancer in Japanese in Japan and in the United States from the Cancer Incidence in Five Continents. Jpn J Clin Oncol, 47:187-188, 2017
18. Katanoda K. Japanese Legacy Cohorts: A New Series of Special Articles Has Started. J Epidemiol, 28:161, 2018
19. Saito E, Inoue M, Sawada N, Charvat H, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Mizoue T, Iso H, Tsugane S. Impact of Alcohol Intake and Drinking Patterns on Mortality From All Causes and Major Causes of Death in a Japanese Population. J Epidemiol, 28:140-148, 2018
20. Narita S, Saito E, Sawada N, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Noda M, Inoue M, Tsugane S. Coffee Consumption and Lung Cancer Risk: The Japan Public Health Center-Based Prospective Study. J Epidemiol, 28:207-213, 2018
21. Shin S, Sawada N, Saito E, Yamaji T, Iwasaki M, Shimazu T, Sasazuki S, Inoue M, Tsugane S. Menstrual and reproductive factors in the risk of thyroid cancer in Japanese women: the Japan Public Health Center-Based Prospective Study. Eur J Cancer Prev, 27:361-369, 2018
22. Nakata K, Ito Y, Magadi W, Bonaventure A, Stiller CA, Katanoda K, Matsuda T, Miyashiro I, Pritchard-Jones K, Rachet B. Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010). Cancer Sci, 109:422-434, 2018
23. Shin S, Saito E, Sawada N, Ishihara J, Takachi R, Nanri A, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Dietary patterns and colorectal cancer risk in middle-aged adults: A large population-based prospective cohort study. Clin Nutr, 37:1019-1026, 2018